Skip to content

Comparison of two adjuvants to 0.5 percent Bupivacaine in Bilateral Erector Spinae Plane Block for postoperative pain in Laparoscopic Cholecystectomy patients.

To study the safety and efficacy of Fentanyl vs Dexmedetomidine as adjuvants to 0.5 percent Bupivacaine in Erector Spinae Plane Block in patients undergoing Laparoscopic Cholecystectomy- A Prospective Randomised Comparative Study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068251
Enrollment
106
Registered
2024-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: To assess the efficacy of 50microgram dexemedetomidine as adjuvant to 0.5% bupivacaine in USG guided b/l ESPB for postoperative analgesia in laparoscopic cholecystectomy patients.: UAAP

Sponsors

Government Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients willing to enroll in the study 2)Patients posted for Laproscopic Cholecystecomy 3)ASA -Class 1& 2 4)Age-18-65 yrs 5)BMI-20-35

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Post operative analgesia will be noted via numerical pain rating score.Timepoint: Post operative analgesia will be noted via numerical pain rating score at 0 mins, 30 mins, 1 hr, 2 hrs, 6hrs, 12 hrs, 24 hrs postoperatively.

Secondary

MeasureTime frame
To identify associated adverse events. To assess requirement of postoperative analgesia. To assess incidence of post operative nausea & vomiting.Timepoint: for a duration of 24hours post operatively.

Countries

India

Contacts

Public ContactDr Attiqa Choudhary

Government Medical College and Hospital , Jammu

naine1978@gmail.com9419781087

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026